Medicine and Dentistry
Acute Kidney Injury
42%
Androgen
27%
Biochemical Recurrence
21%
Carcinogenicity
42%
Castration Resistant Prostate Cancer
42%
Cell Damage
42%
Cystectomy
42%
Dilation Procedure
42%
Disease
57%
Disease Exacerbation
35%
Erectile Dysfunction
47%
Extracorporeal
42%
Extracorporeal Shock Wave Lithotripsy
42%
Extracorporeal Shockwave Therapy
42%
Fluoroscopy
28%
Focal Segmental Glomerulosclerosis
42%
Genitourinary System
42%
Growth Differentiation Factor 15
42%
Hemostat
42%
Hernioplasty
42%
In Vitro
36%
Injury
61%
Isotopes of Calcium
42%
Malignant Neoplasm
23%
Mediator Complex
42%
Meta-Analysis
42%
Metastatic Carcinoma
62%
Microhematuria
42%
Neobladder
42%
Neoplasm
42%
Operation Duration
52%
Percutaneous Nephrolithotomy
84%
Phosphodiesterase V Inhibitor
48%
Postoperative Pain
40%
Prostate Cancer
84%
Randomized Clinical Trial
42%
Recurrent Disease
70%
Stent Placement
31%
Surgical Anastomosis
42%
Symptom
42%
Systematic Review
42%
Testosterone Metabolism
31%
Transitional Cell Carcinoma
42%
Treatment Response
100%
Upregulation
48%
Urethra Stenosis
42%
Urethrotomy
42%
Urinary System
42%
Urolithiasis
56%
Vardenafil
42%
Pharmacology, Toxicology and Pharmaceutical Science
ABCC1
21%
Acute Kidney Failure
42%
Androgen
48%
Biochemical Recurrence
42%
Biological Marker
10%
Bladder Cancer
16%
Carcinogenicity
42%
Castration Resistant Prostate Cancer
42%
Chronic Prostatitis
42%
Disease
51%
Disease Exacerbation
46%
Docetaxel
21%
Doxorubicin
15%
Drug Resistance
21%
Dutasteride
21%
Femoral Hernia
8%
Focal Glomerulosclerosis
42%
Growth Differentiation Factor 15
42%
Hematoma
16%
Hemoperitoneum
8%
Hernia
42%
Inguinal Hernia
8%
Kruppel Like Factor 4
21%
Laceration
8%
Malignant Neoplasm
33%
Mediator Complex
42%
Metastasis
9%
Mouse Model
45%
Multidrug Resistance Protein 1
21%
Neoplasm
42%
Overall Survival
21%
Pelvis Pain Syndrome
42%
Phosphodiesterase V Inhibitor
42%
Postoperative Pain
25%
Prospective Study
16%
Prostate Cancer
84%
Random Effects Model
8%
Randomized Controlled Trial
16%
Recurrence Risk
8%
Recurrent Disease
67%
Retrospective Study
16%
Seroma
16%
Short Hairpin RNA
12%
Surgical Infection
16%
Symptom
10%
Tamsulosin
30%
Therapeutic Effect
10%
Therapy Resistance
12%
Transitional Cell Carcinoma
42%
Vardenafil
42%
Biochemistry, Genetics and Molecular Biology
Allele
16%
Case-Control Study
6%
Cell Damage
42%
Cell Migration
5%
Cell Proliferation
8%
Cochrane Library
8%
down Regulation
11%
Drive
8%
Embase
8%
Enzalutamide
5%
Gene Expression Profiling
7%
Genetic Model
25%
Genetics
42%
Growth Differentiation Factor
42%
Inflammatory Cytokine
14%
Interleukin 6
42%
Interleukin 8
42%
Mediator
7%
Mediator Complex
42%
Medline
8%
Promoter Region
42%
Sample Size
6%
Small Hairpin RNA
10%
SNAI2
5%
SRD5A1
42%
Testosterone Metabolism
14%
Transcription
9%
Upregulation
47%
Web of Science
8%